Interaction of curcumin with manganese may compromise metal and neurotransmitter homeostasis in the hippocampus of young mice

Biological Trace Element Research

Volumn 158, Issue 3, 2014, Pages 399-409

  Schmitz, Ariana Ern ^a   De Oliveira, Paulo Alexandre ^a   De Souza, Luiz F ^a   Da Silva, Danilo Grünig Humberto ^b   Danielski, Samara ^a   Santos, Danúbia Bonfanti ^a   De Almeida, Eduardo Alves ^b   Prediger, Rui Daniel ^a   Fisher, Andrew ^c   Farina, Marcelo ^a   Dafre, Alcir Luiz ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Julio de Mesquita Filho State University   (Brazil)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Curcumin; Idiopathic Parkinson disease; Manganese; Memory; Motor performance

Indexed keywords

CURCUMIN; DOPAMINE; IRON; MANGANESE; METAL; NEUROTRANSMITTER; SEROTONIN; ACETIC ACID DERIVATIVE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CHLORIDE; MANGANESE CHLORIDE; MANGANESE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; CORPUS STRIATUM; DIET SUPPLEMENTATION; EXPOSURE; HIPPOCAMPUS; MALE; MEMORY; MOTOR PERFORMANCE; MOUSE; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; SPATIAL MEMORY; SWISS WEBSTER MOUSE; TASK PERFORMANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; MOTOR ACTIVITY;

MUS;

ACETATES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHLORIDES; CORPUS STRIATUM; CURCUMIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HIPPOCAMPUS; IRON; MALE; MANGANESE; MANGANESE COMPOUNDS; MEMORY; METALS; MICE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; SEROTONIN;

EID: 84901979434     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9951-5     Document Type: Article

References (101)

1. Rivera-Mancía S, Ríos C, Montes S (2011) Manganese accumulation in the CNS and associated pathologies. Biometals 24:811-825
2. Agency for Toxic Substances and Disease Registry (ATSDR) (2012) Toxicological profile for Manganese. U.S. Department of Health and Human Services, Public Health Service, Atlanta
3. Santamaria AB, Cushing CA, Antonini JM, Finley BL, Mowat FS (2007) State-of-the-science review: does manganese exposure during welding pose a neurological risk? J Toxicol Environ Health B Crit Rev 10:417-465 (Pubitemid 47295377)
4. World Health Organization (WHO) (2000) Air quality guidelines for Europe. IOP Publishing PhysicsWeb. http://www.euro.who.int/en/health-topics/ environment-and-health/air-quality/publications/pre2009/air-quality-guidelines- for-europe. Accessed 20 Jan 2014
5. Aschner JL, Aschner M (2005) Nutritional aspects of manganese homeostasis. Mol Aspects Med 26:353-362 (Pubitemid 41225358)
6. Keen CL, Ensunsa JL, Clegg MS (2000) Manganese metabolism in animals and humans including the toxicity of manganese. Met Ions Biol Syst 37:89-121
7. Pace TG, Frank NH (1984) Procedures for estimating probability of nonattainment of a PM10NAAQS using total suspended particulate or inhalable particulate data. U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards, Monitoring and Data Analysis Division, Washington, DC
8. Aschner M, Erikson KM, Dorman DC (2005) Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol 35:1-32 (Pubitemid 40179899)
9. Barbeau A (1984) Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology 5:13-35
10. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W (1994) Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44:1583-1586 (Pubitemid 24286629)
11. Martin CJ (2006) Manganese neurotoxicity: connecting the dots along the continuum of dysfunction. Neurotoxicology 27:347-349
12. Normandin L, Ann Beaupré L, Salehi F, St-Pierre A, Kennedy G, Mergler D et al (2004) Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese. Neurotoxicology 25:433-441 (Pubitemid 38283547)
13. Mergler D (1999) Neurotoxic effects of low level exposure to manganese in human populations. Environ Res 80:99-102
14. Rodier J (1955) Manganese poisoning in Moroccanminers. Br J Ind Med 12:21-35
15. HaMai D, Bondy SC (2004) Oxidative basis of manganese neurotoxicity. Ann N Y Acad Sci 1012:129-141
16. Mena I, Marin O, Fuenzalida S, Cotzias GC (1967) Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17:128-136
17. Cersosimo MG, Koller WC (2006) The diagnosis of manganese-induced parkinsonism. Neurotoxicology 27:340-346 (Pubitemid 44294579)
18. Bonilla E, Prasad AL (1984) Effects of chronic manganese intake on the levels of biogenic amines in rat brain regions. Neurobehav Toxicol Teratol 6:341-344 (Pubitemid 15186568)
19. Cordova FM, Aguiar AS Jr, Peres TV, Lopes MW, Gonçalves FM, Remor AP et al (2012) In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS One 7:e33057
20. Eriksson H, Mägiste K, Plantin LO, Fonnum F, Hedström KG, Theodorsson-Norheim E et al (1987) Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch Toxicol 61:46-52 (Pubitemid 17149975)
21. Komura J, Sakamoto M (1992) Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: long-term oral administration of several manganese compounds. Environ Res 57:34-44
22. Betharia S, Maher TJ (2012) Neurobehavioral effects of lead and manganese individually and in combination in developmentally exposed rats. Neurotoxicology 33:1117-1127
23. Blecharz-Klin K, Piechal A, Joniec-Maciejak I, Pyrzanowska J, Widy-Tyszkiewicz E (2012) Effect of intranasal manganese administration on neurotransmission and spatial learning in rats. Toxicol Appl Pharmacol 265:1-9
24. Grünecker B, Kaltwasser SF, Zappe AC, Bedenk BT, Bicker Y, Spoormaker VI et al (2012) Regional specificity of manganese accumulation and clearance in the mouse brain: implications for manganese-enhanced MRI. NMR Biomed 26:242-256
25. Torres-Agustín R, Rodríguez-Agudelo Y, Schilmann A, Solís-Vivanco R, Montes S, Riojas-Rodríguez H et al (2012) Effect of environmental manganese exposure on verbal learning andmemory in Mexican children. Environ Res 121:39-44
26. Archibald FS, Tyree C (1987) Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys 256:638-650 (Pubitemid 17128522)
27. +3. Neurodegeneration 4:329-334
28. Chen JY, Tsao GC, Zhao Q, Zheng W (2001) Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes. Toxicol Appl Pharmacol 175:160-168 (Pubitemid 32848507)
29. Perez-Vizcaino F, Duarte J, Santos-Buelga C (2012) The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids. J Sci Food Agric 92(9):1822-1825
30. Cole GM, Teter B, Frautschy SA (2007) Neuroprotective effects of curcumin. Adv Exp Med Biol 595:197-212
31. Hwang S-L, Shih P-H, Yen G-C (2012) Neuroprotective effects of citrus flavonoids. J Agric Food Chem 60:877-885
32. Park HY, Kim G-Y, Choi YH (2012) Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Int J Mol Med 30:204-210
33. Menon LG, Kuttan R, Kuttan G (1999) Anti-metastatic activity of curcumin and catechin. Cancer Lett 141:159-165 (Pubitemid 29261735)
34. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363-398 (Pubitemid 36361976)
35. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79-83
36. Sugiyama Y, Kawakishi S, Osawa T (1996) Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 52:519-525 (Pubitemid 26253384)
37. Sharma OP (1976) Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25:1811-1812
38. Venkatesan N, Punithavathi D, Arumugam V (2000) Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol 129:231-234 (Pubitemid 30072641)
39. Venkatesan N (1998) Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 124:425-427
40. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P (2007) Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta 1770:989-996 (Pubitemid 46621136)
41. Carmona-Ramírez I, Santamaría A, Tobón-Velasco JC, Orozco-Ibarra M, González-Herrera IG, Pedraza-Chaverrí J et al (2013) Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity. J Nutr Biochem 24:14-24
42. Huang H-C, Xu K, Jiang Z-F (2012) Curcumin-mediated neuroprotection against amyloid-β-induced mitochondrial dysfunction involves the inhibition of GSK-3β. J Alzheimers Dis 32:981-996
43. Mansouri Z, Sabetkasaei M, Moradi F, Masoudnia F, Ataie A (2012) Curcumin has neuroprotection effect on homocysteine rat model of Parkinson. J Mol Neurosci 47:234-242
44. Wu J, Li Q, Wang X, Yu S, Li L, Wu X et al (2013) Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 8:e59843
45. Tripanichkul W, Jaroensuppaperch E (2012) Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. Int J Neurosci 122:263-270
46. Rajeswari A, Sabesan M (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in amodel of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16:96-99 (Pubitemid 351521747)
47. Milatovic D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M (2009) Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol 240:219-225
48. Perfeito R, Cunha-Oliveira T, Rego AC (2012) Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease - resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med 53:1791-1806
49. Seet RCS, Lee C-YJ, Lim ECH, Tan JJH, Quek AML, Chong W-L et al (2010) Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radic Biol Med 48:560-566
50. Taylor MD, Erikson KM, Dobson AW, Fitsanakis VA, Dorman DC, Aschner M (2006) Effects of inhaled manganese on biomarkers of oxidative stress in the rat brain. Neurotoxicology 27:788-797 (Pubitemid 44232991)
51. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R et al (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371:887-895 (Pubitemid 36578887)
52. Dairam A, Fogel R, Daya S, Limson JL (2008) Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J Agric Food Chem 56:3350-3356 (Pubitemid 351746066)
53. Ordoñez-Librado JL, Gutierrez-Valdez AL, Colín-Barenque L, Anaya-Martínez V, Díaz-Bech P, Avila-Costa MR (2008) Inhalation of divalent and trivalent manganese mixture induces a Parkinson's disease model: immunocytochemical and behavioral evidences. Neuroscience 155:7-16
54. Sanchez-Betancourt J, Anaya-Martínez V, Gutierrez-Valdez AL, Ordoñez-Librado JL, Montiel-Flores E, Espinosa-Villanueva J et al (2012) Manganese mixture inhalation is a reliable Parkinson disease model in rats. Neurotoxicology 33:1346-1355
55. Ordoñez-Librado JL, Anaya-Martínez V, Gutierrez-Valdez AL, Colín-Barenque L, Montiel-Flores E, Avila-Costa MR (2010) Manganese inhalation as a Parkinson disease model. Park Dis 2011:612989
56. Ordoñez-Librado JL, Anaya-Martinez V, Gutierrez-Valdez AL, Montiel-Flores E, Corona DR, Martinez-Fong D et al (2010) L-DOPA treatment reverses the motor alterations induced by manganese exposure as a Parkinson disease experimental model. Neurosci Lett 471:79-82
57. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME et al (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22:993-1005 (Pubitemid 34070638)
58. Jyoti A, Sethi P, Sharma D (2009) Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis. Epilepsy Behav 14:300-308
59. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS et al (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892-5901 (Pubitemid 40280072)
60. Whishaw IQ (2000) Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat. Neuropharmacology 39:788-805
61. Rial D, Duarte FS, Xikota JC, Schmitz AE, Dafré AL, Figueiredo CP et al (2009) Cellular prion protein modulates age-related behavioral and neurochemical alterations in mice. Neuroscience 164:896-907
62. Almeida EA, Bainy ACD, Medeiros MHG, Di Mascio P (2003) Effects of tracemetal and exposure to air on serotonin and dopamine levels in tissues of the mussel Perna perna. Mar Pollut Bull 46:1485-1490 (Pubitemid 37371901)
63. Jackson GM, Jackson SR, Hindle JV (2000) The control of bimanual reach-to-grasp movements in hemiparkinsonian patients. Exp Brain Res 132:390-398 (Pubitemid 30330215)
64. Santos D, Milatovic D, Andrade V, Batoreu MC, Aschner M, Marreilha dos Santos AP (2012) The inhibitory effect ofmanganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology 292:90-98
65. Vezér T, Papp A, Hoyk Z, Varga C, Náray M, Nagymajtényi L (2005) Behavioral and neurotoxicological effects of subchronic manganese exposure in rats. Environ Toxicol Pharmacol 19:797-810
66. Adler CH (2011) Premotor symptoms and early diagnosis of Parkinson's disease. Int J Neurosci 121(Suppl 2):3-8
67. Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244:2-8 (Pubitemid 26413891)
68. Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239-1245 (Pubitemid 41508217)
69. Erikson KM, John CE, Jones SR, Aschner M (2005) Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter. Environ Toxicol Pharmacol 20:390-394 (Pubitemid 41318051)
70. Stredrick DL, Stokes AH, Worst TJ, Freeman WM, Johnson EA, Lash LH et al (2004) Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology 25:543-553 (Pubitemid 38739112)
71. Chang Y, Lee J-J, Seo J-H, Song H-J, Kim J-H, Bae S-J et al (2010) Altered working memory process in the manganese-exposed brain. NeuroImage 53:1279-1285
72. Schneider JS, Decamp E, Koser AJ, Fritz S, Gonczi H, Syversen T et al (2006) Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res 1118:222-231 (Pubitemid 44633869)
73. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531 (Pubitemid 26403928)
74. Dong S, Zeng Q, Mitchell ES, Xiu J, Duan Y, Li C et al (2012) Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One 7:e31211
75. Sethi P, Jyoti A, Hussain E, Sharma D (2009) Curcumin attenuates aluminium-induced functional neurotoxicity in rats. Pharmacol Biochem Behav 93:31-39
76. Khuwaja G, Khan MM, Ishrat T, Ahmad A, Raza SS, Ashafaq M et al (2011) Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies. Brain Res 1368:254-263
77. Manto M, Bower JM, Conforto AB, Delgado-García JM, da Guarda SNF, Gerwig M et al (2012) Consensus Paper: roles of the cerebellum in motor control - the diversity of ideas on cerebellar involvement in movement. Cerebellum 11:457-487
78. Wolpaw JR, Chen XY (2006) The cerebellum in maintenance of a motor skill: a hierarchy of brain and spinal cord plasticity underlies H-reflex conditioning. Learn Mem 13:208-215
79. Rüegg DG, Juvet P (1984) Contributions of the motor cortex and the cerebellum to a simple learned movement in the monkey. Neurosci Lett 46:235-239 (Pubitemid 14147497)
80. Filip P, Lungu OV, Bareš M (2013) Dystonia and the cerebellum: a new field of interest in movement disorders? Clin Neurophysiol 124:1269-1276
81. Jaques JA dos S, Rezer JFP, Carvalho FB, da Rosa MM, Gutierres JM, Gonçalves JF, et al (2012) Curcumin protects against cigarette smoke-induced cognitive impairment and increased acetylcholinesterase activity in rats. Physiol Behav 106:664-669
82. Jaques JADS, Doleski PH, Castilhos LG, da Rosa MM, Souza V do CG, Carvalho FB, et al (2013) Free and nanoencapsulated curcumin prevents cigarette smoke-induced cognitive impairment and redox imbalance. Neurobiol Learn Mem 100C:98-107
83. Shohamy D, Adcock RA (2010) Dopamine and adaptive memory. Trends Cogn Sci (Regul Ed) 14:464-472
84. Xu Y, Ku B-S, Yao H-Y, Lin Y-H, Ma X, Zhang Y-H et al (2005) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82:200-206 (Pubitemid 41423504)
85. Kulkarni SK, Bhutani MK, Bishnoi M (2008) Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 201:435-442
86. Du X-X, Xu H-M, Jiang H, Song N, Wang J, Xie J-X (2012) Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. Neurosci Bull 28:253-258
87. Heim KE, Tagliaferro AR, Bobilya DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13:572-584 (Pubitemid 35246546)
88. +)-β-amyloid: not just serving as suicide antioxidants! Inorg Chem 52:679-690
89. Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer 's disease animal models. J Alzheimers Dis 6:367-377 (Pubitemid 39287248)
90. Sumanont Y, Murakami Y, Tohda M, Vajragupta O, Watanabe H, Matsumoto K (2007) Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. Biol Pharm Bull 30:1732-1739 (Pubitemid 47403254)
91. Lambert JD, Sang S, Yang CS (2007) Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol 20:583-585 (Pubitemid 46762092)
92. Rietjens IMCM, Boersma MG, de Haan L, Spenkelink B, Awad HM, Cnubben NHP et al (2002) The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol 11:321-333 (Pubitemid 34694012)
93. Sahu SC, Gray GC (1993) Interactions of flavonoids, trace metals, and oxygen: nuclear DNA damage and lipid peroxidation induced by myricetin. Cancer Lett 70:73-79 (Pubitemid 23219862)
94. Sugihara N, Arakawa T, Ohnishi M, Furuno K (1999) Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid. Free Radic Biol Med 27:1313-1323 (Pubitemid 30001494)
95. Ahsan H, Parveen N, Khan NU, Hadi SM (1999) Pro-oxidant, antioxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact 121:161-175 (Pubitemid 29299407)
96. Huang H-C, Lin C-J, Liu W-J, Jiang R-R, Jiang Z-F (2011) Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(II). Food Chem Toxicol 49:1578-1583
97. Nair J, Strand S, Frank N, Knauft J, Wesch H, Galle PR et al (2005) Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 26:1307-1315 (Pubitemid 41417910)
98. Martins R de P, Braga H de C, da Silva AP, Dalmarco JB, de Bem AF, dos Santos ARS, et al (2009) Synergistic neurotoxicity induced by methylmercury and quercetin in mice. Food Chem Toxicol 47:645-649
99. Li Y, He Y, Guan Q, Liu W, Han H, Nie Z (2012) Disrupted iron metabolism and ensuing oxidative stress may mediate cognitive dysfunction induced by chronic cerebral hypoperfusion. Biol Trace Elem Res 150:242-248
100. Umur EE, Oktenli C, Celik S, Tangi F, Sayan O, Sanisoglu YS et al (2011) Increased iron and oxidative stress are separately related to cognitive decline in elderly. Geriatr Gerontol Int 11:504-509
101. Napolitano A, Manini P, d'Ischia M (2011) Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr Med Chem 18:1832-1845